诺沃库尔

最新新闻

• 评级变动
  H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Cuts Target Price to $46
  \u5e02\u573a\u8d44\u8baf · 2026/6/18
• 评级变动
  Ladenburg Thalmann & Co. Remains a Buy on NovoCure (NVCR)
  TipRanks · 2026/2/27
• 评级变动
  J.P. Morgan Sticks to Its Hold Rating for NovoCure (NVCR)
  TipRanks · 2026/7/13
• H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $46
  \u5e02\u573a\u8d44\u8baf · 2026/7/13
• H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Raises Target Price to $52
  \u5e02\u573a\u8d44\u8baf · 2026/7/24
• J.P. Morgan Maintains Novocure(NVCR.US) With Hold Rating, Cuts Target Price to $17
  \u5e02\u573a\u8d44\u8baf · 2026/7/13
• 评级变动
  Evercore Maintains Novocure(NVCR.US) With Buy Rating, Cuts Target Price to $16
  \u5e02\u573a\u8d44\u8baf · 2026/4/6
• Wedbush Maintains Novocure(NVCR.US) With Hold Rating, Raises Target Price to $20
  \u5e02\u573a\u8d44\u8baf · 2026/7/24
• 评级变动
  H.C. Wainwright Keeps Their Buy Rating on NovoCure (NVCR)
  TipRanks · 2026/4/21
• 评级变动
  Wells Fargo Maintains Novocure(NVCR.US) With Hold Rating, Raises Target Price to $17
  \u5e02\u573a\u8d44\u8baf · 2026/5/4
• 评级变动
  H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $49
  \u5e02\u573a\u8d44\u8baf · 2026/4/21
• 评级变动
  Piper Sandler Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $27
  \u5e02\u573a\u8d44\u8baf · 2026/5/26
• 评级变动
  Evercore Maintains Novocure(NVCR.US) With Buy Rating, Raises Target Price to $20
  \u5e02\u573a\u8d44\u8baf · 2026/5/1
• 评级变动
  H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Raises Target Price to $49
  \u5e02\u573a\u8d44\u8baf · 2026/2/27
• 评级变动
  H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Raises Target Price to $47
  \u5e02\u573a\u8d44\u8baf · 2026/2/12
• 评级变动
  H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $48
  \u5e02\u573a\u8d44\u8baf · 2026/5/1
• 评级变动
  H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $39
  \u5e02\u573a\u8d44\u8baf · 2026/2/6
• 评级变动
  H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Cuts Target Price to $48
  \u5e02\u573a\u8d44\u8baf · 2026/5/1
• 评级变动
  Leerink Partners Maintains Novocure(NVCR.US) With Buy Rating, Cuts Target Price to $24
  \u5e02\u573a\u8d44\u8baf · 2026/1/13
• H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $52
  \u5e02\u573a\u8d44\u8baf · 2026/7/24

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。